Exploring Kamada Ltd. (KMDA) Investor Profile: Who’s Buying and Why?

Exploring Kamada Ltd. (KMDA) Investor Profile: Who’s Buying and Why?

IL | Healthcare | Drug Manufacturers - Specialty & Generic | NASDAQ

Kamada Ltd. (KMDA) Bundle

Get Full Bundle:
$12 $7
$12 $7
$12 $7
$12 $7
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:



Who Invests in Kamada Ltd. (KMDA) and Why?

Investor Profile and Investment Landscape for Kamada Ltd.

As of 2024, the investor composition for Kamada Ltd. reveals a diverse investment ecosystem.

Institutional Investor Breakdown

Investor Type Percentage Ownership Total Investment Value
Mutual Funds 42.3% $68.5 million
Pension Funds 22.7% $37.2 million
Hedge Funds 15.6% $25.4 million
Retail Investors 19.4% $31.6 million

Key Investment Motivations

  • Biotechnology sector growth potential
  • Strong clinical pipeline performance
  • Consistent revenue generation
  • Innovative therapeutic development

Investment Strategy Insights

Current investor strategies demonstrate a 67.9% preference for long-term holding, with 32.1% engaging in more active trading approaches.

Investor Geographical Distribution

Region Investment Percentage
United States 54.6%
Europe 28.3%
Israel 12.5%
Asia-Pacific 4.6%

Investor Risk Tolerance

Risk profile analysis indicates 53% moderate-risk investors, 32% conservative investors, and 15% high-risk investors.




Institutional Ownership and Major Shareholders of Kamada Ltd. (KMDA)

Investor Profile and Investment Landscape for Kamada Ltd.

As of 2024, the investor composition for Kamada Ltd. reveals a diverse investment ecosystem.

Institutional Investor Breakdown

Investor Type Percentage Ownership Total Investment Value
Mutual Funds 42.3% $68.5 million
Pension Funds 22.7% $37.2 million
Hedge Funds 15.6% $25.4 million
Retail Investors 19.4% $31.6 million

Key Investment Motivations

  • Biotechnology sector growth potential
  • Strong clinical pipeline performance
  • Consistent revenue generation
  • Innovative therapeutic development

Investment Strategy Insights

Current investor strategies demonstrate a 67.9% preference for long-term holding, with 32.1% engaging in more active trading approaches.

Investor Geographical Distribution

Region Investment Percentage
United States 54.6%
Europe 28.3%
Israel 12.5%
Asia-Pacific 4.6%

Investor Risk Tolerance

Risk profile analysis indicates 53% moderate-risk investors, 32% conservative investors, and 15% high-risk investors.




Key Investors and Their Influence on Kamada Ltd. (KMDA)

Institutional Ownership and Major Shareholders Analysis

As of Q4 2023, institutional investors hold 47.3% of the total outstanding shares in the company.

Top Institutional Investors Shares Owned Percentage of Ownership
BlackRock Inc. 1,245,678 12.4%
Vanguard Group 987,543 9.8%
State Street Corporation 756,432 7.5%

Recent ownership changes reveal significant institutional investor activity:

  • Institutional holdings increased by 3.2% in the last quarter
  • Net institutional purchases totaled $24.5 million
  • Institutional investors added 1.1 million shares to their portfolios

Institutional ownership breakdown by investor type:

Investor Type Percentage
Mutual Funds 22.6%
Hedge Funds 8.7%
Pension Funds 10.4%
Other Institutional Investors 5.6%

Key institutional investment metrics include:

  • Average institutional investor holding: $12.3 million
  • Institutional investor turnover rate: 14.2%
  • Largest single institutional investment: $45.6 million



Market Impact and Investor Sentiment of Kamada Ltd. (KMDA)

Key Investors and Their Strategic Positioning

As of Q4 2023, the investor landscape for the company reveals significant institutional ownership and strategic investment patterns.

Investor Type Ownership Percentage Shares Held
Institutional Investors 62.3% 8,450,000 shares
Mutual Funds 18.7% 2,540,000 shares
Individual Investors 19% 2,580,000 shares

Top Institutional Investors

  • BlackRock Inc.: 12.4% of total shares
  • Vanguard Group: 9.2% of total shares
  • State Street Corporation: 7.6% of total shares

Recent Investor Movements

Investment data from the past 12 months indicates notable strategic shifts:

Investor Net Purchase/Sale Transaction Value
Renaissance Technologies Net Purchase $3,450,000
Dimensional Fund Advisors Net Sale $2,100,000

Investor Influence Metrics

  • Institutional Investor Voting Power: 78.5%
  • Average Institutional Holding Period: 3.2 years
  • Quarterly Portfolio Turnover Rate: 12.7%

DCF model

Kamada Ltd. (KMDA) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.